Clinical Trials in Detroit

Showing 9801-9820 of 19,719 trials

Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects

NCT04181476

The purpose of this study is to evaluate the efficacy of topical products in providing protection against the visible light and ultraviolet A1 (UVA1) part of sunlight. Ultraviolet radiation and visible light are both components of sunlight that reach the earth. It is important to test these topical products against visible light and UVA1 because our current sunscreens may not protect against these very well.

Sun Damaged Skin

Henry Ford Health System12 participantsStarted Nov 2019

Detroit, Michigan, United States

COMPLETEDPhase 3< 1 mile

Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer

NCT03269344

Strategies to minimize and mitigate external beam radiation therapy related mucositis and pain during the treatment of head and neck cancer remain limited. The investigators hypothesize that gabapentin could be used to delay or reduce treatment-related pain, reliance on opioid medication, and improve the quality of life for these patients.

Oropharynx Cancer

Henry Ford Health System65 participantsStarted Jun 2017

Detroit, Michigan, United States

TERMINATEDPhase 3< 1 mile

Study of TV-1106 in Growth Hormone-Deficient Adults

NCT02410343

The primary objective of this study is to determine the efficacy of 6 months of treatment with TV-1106 compared with placebo on body fat composition.

Growth Hormone Deficiency

Teva Branded Pharmaceutical Products R&D, Inc.14 participantsStarted Apr 2015

Artesia, California, United States • Fountain Valley, California, United States • Fountain Valley, California, United States +30 more locations

Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects

Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer

Study of TV-1106 in Growth Hormone-Deficient Adults

Find Trials by Condition in Detroit

Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients

Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis

Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes

Granulation Tissue Treatment: Silver Nitrate vs Kenalog vs Washcloth Abrasion

A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)

A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)

A Phase 2 Study of CIM331 for Atopic Dermatitis Patients

Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia

Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance

UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder

Cook IVC Filter Study

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread

RHA® Redensity With New Anesthetic Agent - Perioral Rhytids

IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors

Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients

Argus® II Retinal Stimulation System Feasibility Protocol

Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment